Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
MF Scheme SnapShots
Check out details of a particular scheme along with the latest NAV for various time periods. You can widen your search on the basis of the Fund House, Category and particular Scheme.
Tata India Pharma & Healthcare Fund(G)-Direct Plan
 
Summary
Fund Name Tata Mutual Fund  
Scheme Name Tata India Pharma & Healthcare Fund(G)-Direct Plan  
AMC Tata Asset Management Private Limited  
Type Open ended scheme  
Category Equity - Sectoral Fund - Pharma & Health Care  
Launch Date 28-Dec-15  
Fund Manager Meeta Shetty , Rajat Srivastava  
Face Value 10  
Custodian Standard Chartered Bank  
Net Assets (Rs. cr) 1213.92  
AMC Details
Tata Asset Management Private Limited
1903, B Wing, Parinee Crescenzo, G Block,
Bandra Kurla Complex, Bandra East,
Mumbai - 400 051
Phone : 022 6282 7777
Fax : +91 (22) 22613782
service@tataamc.com
www.tatamutualfund.com
Registrar & Transfer Agent Details
Computer Age Management Services Limited
178 / 10, Kodambakkam High Road,
Opp. Palmgroove Hotel, M.G.R. Salai, Nungambakkam,
Chennai - 600 034
(044) 39115574, 39115583
(044) 28291521
camslb@camsonline.com
www.camsonline.com
 
 
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.